Abstract
Idiopathic pulmonary fibrosis (IPF) is a disease characterized by widespread fibrotic and inflammatory abnormalities of the lung. A multidisciplinary approach is particularly important when deciding to perform additional diagnosis assessments, integrating biopsy results with clinical and CT feature. Respiratory failure is a common complication in advanced stages: oxygen supplementation and ventilator support need to be titrated according to the severity of ARF. High-Flow Nasal oxygen may be an alternative to conventional oxygen therapy in patients requiring high-flow and high oxygen concentration to correct hypoxemia and control dyspnea. Neither Non-Invasive Ventilation (NIV) nor Invasive Mechanical Ventilation (IMV) seem to change the poor outcomes associate to advanced stages of IPF, however, in selected patients, such as those with less severe ARF a NIV trial might help in the patients who may present a better short-term prognosis. More invasive techniques, including IMV and Extracorporeal Membrane Oxygenation (ECMO) should be limited to patients listed for lung transplant.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kaunisto J, Salomaa E-R, Hodgson U, Kaarteenaho R, Mylarniemi M. Idiopathic pulmonary fibrosis—a systematic review on methodology the collection of epidemiological data. BMC Pulm Med. 2013;13:53.
Garcia CK. Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc Am Thorac Soc. 2011;8:158–62.
Walsh SL, Wells AU, Desai SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016;4:557–65.
Zappala CJ, Latsi PI, Nicholson AG, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35:830–6.
Raghu G, Collard HP, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.
Raghu G, Remi-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guidelines. Am J Respir Crit Care Med. 2018;198:e44–68.
Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6(2):138–53.
Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidences, risk factors and outcome. Eur Respir J. 2011;37:356–63.
Lederer D, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378:1811–23.
Richeldi L, du Bois LM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–82.
Frat JP, Coudrov R, Marianovic N, Thille AW. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann Transl Med. 2017;5(14):297.
Vianello A, Arcano G, Battistella L, Vio S, Concas A, et al. Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis. J Crit Care. 2014;29:562–7.
Faverio P, De Giacomi F, Sardella L, Fiorentini G, Carone M, et al. Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights. BMC Pulm Med. 2018;18:70.
Vianello A, Arcano G, Paladini L, Iovino S. Successful management of acute respiratory failure in an idiopathic pulmonary fibrosis patient using an extracorporeal carbon dioxide removal system. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:186–90.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Farris, B. (2020). Acute Hypoxemic Respiratory Failure: Idiopathic Pulmonary Fibrosis. In: Esquinas, A., Vargas, N. (eds) Ventilatory Support and Oxygen Therapy in Elder, Palliative and End-of-Life Care Patients . Springer, Cham. https://doi.org/10.1007/978-3-030-26664-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-26664-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26663-9
Online ISBN: 978-3-030-26664-6
eBook Packages: MedicineMedicine (R0)